Building Uncertainty Into Cost-Effectiveness Rankings
- 1 May 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Medical Care
- Vol. 38 (5) , 460-468
- https://doi.org/10.1097/00005650-200005000-00003
Abstract
Current principles of cost-effectiveness analysis emphasize the rank ordering of programs by expected economic return (eg, quality-adjusted life-years gained per dollar expended). This criterion ignores the variance associated with the cost-effectiveness of a program, yet variance is a common measure of risk when financial investment options are appraised. Variation in health care program return is likely to be a criterion of program selection for health care managers with fixed budgets and outcome performance targets. Characterizing health care resource allocation as a risky investment problem, we show how concepts of portfolio analysis from financial economics can be adopted as a conceptual framework for presenting cost-effectiveness data from multiple programs as mean-variance data. Two specific propositions emerge: (1) the current convention of ranking programs by expected return is a special case of the portfolio selection problem in which the decision maker is assumed to be indifferent to risk, and (2) for risk-averse decision makers, the degree of joint risk or covariation in cost-effectiveness between programs will create incentives to diversify an investment portfolio. The conventional normative assumption of risk neutrality for social-level public investment decisions does not apply to a large number of health care resource allocation decisions in which health care managers seek to maximize returns subject to budget constraints and performance targets. Portfolio theory offers a useful framework for studying mean-variance tradeoffs in cost-effectiveness and offers some positive predictions (and explanations) of actual decision making in the health care sector.Keywords
This publication has 16 references indexed in Scilit:
- Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulationStatistics in Medicine, 1999
- Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticalsHealth Economics, 1999
- Uncertainty in Decision Models Analyzing Cost-EffectivenessMedical Decision Making, 1998
- Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimationHealth Economics, 1997
- Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four MethodsHealth Economics, 1997
- ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIALStatistics in Medicine, 1996
- Confidence intervals for cost-effectiveness ratios: An application of Fieller's theoremHealth Economics, 1996
- Confidence intervals for cost/effectiveness ratiosHealth Economics, 1995
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994
- In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health CareMedical Care, 1994